Cargando…
Non-responders to topical Imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10
Autor principal: | Liu, X S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939795/ https://www.ncbi.nlm.nih.gov/pubmed/20664597 http://dx.doi.org/10.1038/sj.bjc.6605824 |
Ejemplares similares
-
Use of topical imiquimod in the treatment of VIN: a case report and review of the literature
por: Grimes, Chelsea, et al.
Publicado: (2016) -
Comparison of CFR among vaccinated, partially vaccinated and unvaccinated study participants of VIN-WIN study
por: Pasi, A.R.
Publicado: (2022) -
Kaposi's sarcoma responding to topical imiquimod 5% cream: a case report
por: Benomar, Sophia, et al.
Publicado: (2009) -
Pityriasis rubra pilaris induced by topical use of imiquimod 5%()
por: Armillas-Lliteras, Lucia, et al.
Publicado: (2023) -
Recurrence of vulval intraepithelial neoplasia following treatment with cidofovir or imiquimod: results from a multicentre, randomised, phase II trial (RT3VIN)
por: Hurt, CN, et al.
Publicado: (2018)